搜索到 1000 条关于 56c텔레popkonDB!ㅡ맘카페디비$)" 的文章
-
-
2016.10.24 哀悼!我国著名神经外科专家罗其中教授 10 月 23 日凌晨因病去世
我国著名神经外科专家罗其中教授,因病医治无效,于 2016 年 10 月 23 日凌晨 1 点 56 分在仁济医院逝世,享年 81 岁。仁济医院在官方微信发布讣告。罗其中,教授、主任医师、博士后导师,上海交通大学医学院附属仁济医院神经外科学科带头人,上海市颅脑创伤研究所学术委员会主任委员,中国医学科学院神经科学
-
-
2025.04.30 我只当「时髦精」---二氧化碳培养箱的自白
小 C 的自白大家好,我是小 C,在别人眼里,我外表憨厚,有强大的包容性,但私底下我其实是一只「精致时髦精」。点击了解详情燃烧我的卡路里作为一名都市丽人,当其他人在享受愉悦的休闲时光时,我已经在去往健身房的路上,只为增强自己的身体素质。我的眼睛就是尺精致的人生不需要解释,我的眼睛就是尺,没有人比我更了解,谁才是我真正
-
-
2016.06.22 溺水急救:伪科学太多 孩子好苦
按压(Compression),即采用传统的A-B-C心肺复苏急救顺序。切记同时呼叫120,并持续复苏至患者呼吸脉搏恢复或急救人员到达。溺水者心脏骤停,C-A-B还是A-B-C?2010年心肺复苏指南最重要的更新是将复苏的急救顺序从A-B-C改为C-A-B,甚至提倡单纯胸外按压,而为何在溺水心脏骤停者却推荐A-B-C呢
-
-
2018.05.15 Selected References for GelRed™ and GelGreen™
GelRed, agarose gels Boulet, G.A., Micalessi, I.M., Horvath, C.A., Benoy, I.H., Depuydt, C.E., and Bogers, J.J. (2010)。 Nucleic acid sequence- based
-
-
2012.09.14 2011 年美国肝病研究会基因1型慢性丙肝临床实践指南
The standard of care (SOC) therapy for patients with chronic hepatitis C... hepatitis C (CHC) that have changed the optimal treatment regimen of genotype 1
-
-
2016.08.18 第三方药品零售被叫停 网店或失去重要流量入口?
:企业与企业之间的交易(B2B),主要为生产企业、流通企业或批发商通过自身网站与其他企业的互联网交易C 证:连锁药店自建的网上药店向个人消费者提供药品(B2C...网上零售类 B2C 证书(C 证),新增 122 家。据不完全统计,2015 年商务部直报系统医药电商销售总额达 476 亿元,其中 B2B 市场规模达 444
-
-
2016.10.24 泌尿外科「教父」Walsh 教授来解放军总医院访问
2016 年 10 月 21 日,约翰霍普金斯大学 Patrick C. Walsh 教授来我院泌尿外科访问,解放军总医院任国荃院长专程接见了 Patrick C. Walsh 教授,双方就两院合作,展开了深入的讨论。图 1 解放军总医院任国荃院长专程接见 Patrick C. Walsh 教授图 2 解放军总医院任
-
-
2014.11.21 AHA2014:PCSK9单抗有望用于他汀不耐受患者
ODYSSEY替代研究发现,在研PCSK9单抗alirocumab在他汀不耐受的高LDL-C患者中降LDL-C水平显著优于依泽替米贝,后者正是目前该类患者的... ODYSSEY替代研究结果ODYSSEY替代研究招募了361名他汀不耐受的患者,包括极高心血管风险且LDL-C >70 mg/dL的患者和中/高心血管
-
-
2012.10.30 FDA批准利那洛肽治疗便秘
美国FDA批准了利那洛肽(Linzess,Ironwood制药公司)用于治疗成人慢性特发性便秘和便秘型肠易激综合症(IBS-C)。生产商称:该药(利那洛肽)是鸟苷酸环化酶C(GC-C)激动剂的胶囊制剂,每日口服一次。血浆浓度检测不到的利那洛肽与肠道GC-C结合后,导致细胞内和细胞外
-
2013.02.06 2013冬季风湿病学临床研讨会
官方网站:www.r-w-c-s.com/2013/index-2013.html会议时间:2013/2/6-2013/2/9 地点:美国夏威夷
-
-
2015.05.16 ASCO2015:AZD1775对铂类敏感的TP53突变的卵巢癌有效
Amit M. Oza等人参与一项铂类敏感的TP53突变的卵巢癌患者AZD1775+紫杉醇和卡铂(P/C)方案化疗的国际性II期临床试验结果将于2015年6月...。晚期实体瘤患者能良好耐受AZD1775+C治疗。Amit M. Oza等人研究AZD1775+P/C与P/C两种方案治疗TP53突变的卵巢癌患者的有效性
-
-
2016.08.17 神经科的那些病例:反应迟钝伴两便失禁 1 例
女性,56 岁,反应迟钝伴两便失禁 1 周余。3 周前患者无明显诱因突发「感冒样」症状,畏寒乏力,伴精神萎靡,无发热。1 周前出现明显反应迟钝、言语减少,思睡...后状态解释;c. 发病 3 月及其后无新症状及新病灶;d. 急性期(发病 3 月内)头颅 MR 存在异常信号;e. 典型 MR 表现为大的(>1~2 cm
-
-
2017.03.20 套细胞淋巴瘤更好的初始治疗方案:R-CHOP+ 90Y-替伊莫单抗
替伊莫单抗治疗是否能提高疗效?美国福克斯蔡斯癌症中心的 Smith 教授等分析了 2003 年 11 月至 2005 年 2 月 56 例 MCL 患者采取缩短...来看看吧。研究纳入的是 56 例未经治疗、器官功能正常的 MCL 患者,中位年龄 60 岁。治疗方案:每 3 周给予标准剂量 R-CHOP,共 4 个周期,第 4
-
-
2018.01.24 VC 能预防感冒,用药剂量、时机你知道吗?
最近流感肆掠,听说维生素 C 能预防感冒?在「用药助手」上搜了下维 C 的「适应症」,也没看到有能预防感冒着一说。今日问答:外界一直传的沸沸扬扬的维 C 能预防感冒是真的吗?有文献、实验支持吗?做预防用,剂量、时机你知道吗?参考答案:站友 @漩涡一拳 分享:维生素 C 能预防感冒吗?能!(那剂量、时机
-
-
2020.12.22 妙手仁心保健康 解除病痛笑开颜
腰椎间盘突出症是我们日常生活中较为常见的疾病之一,你是否正在遭受这样的困扰呢?让我们来看看上海市第二康复医院疼痛康复科李少敏医生接诊的这位患者的经历吧!就医过程这是一位男患者,今年 56 岁,既往有腰椎间盘突出症多年,时常有腰痛,多次至外院治疗,但疼痛无明显改善。近日患者因着凉后突发腰痛加重伴右下肢疼痛、行走
-
-
2016.09.05 糖化血红蛋白 7.5%~9%:起始联合治疗?起始不联合治疗?
内分泌(ADA/EASD/AACE)治疗指南均建议,新诊断的 2 型糖尿病患者在改善生活方式的同时使用二甲双胍治疗,起始 HbA1c>7.5% 或> 9% 的患者使用联合治疗。但是,对于 HbA1c 在 7.5% ~ 9% 之间的患者的管理仍存在争议,是否需要联合治疗以及基于病理生理学机制的联合治疗是否优于
-
2012.09.19 16th Congress of the Asian Pacific Society of Respirology


16th Congress of the Asian Pacific Society of Respirology
3 – 6 November, 2011, Shanghai
www.apsr2011.orgWelcome message from the Honorary Congress PresidentOn behalf of the Local Congress Committee, it is my honor to cordially invite you all to the 16th APSR. In its 16th year, the APSR Congress has been welcomed for the third time to China and we consider it a great honor to host this event, for the first time in Shanghai. The Congress venue will be the Shanghai International Convention Center. The APSR, Chinese Society of Respiratory Diseases and Shanghai Medical Association have joined forces as co-organizers of the Congress to bring together physicians, academics, healthcare professionals and decision makers in the field of respiratory medicine from around the world to discuss emerging issues and exchange ideas on current research and clinical topics in respirology.The Congress has been designed to provide an innovative and comprehensive overview of the latest research developments in respirology, primarily in conditions commonly found in the Asia Pacific region. The meeting will invite many distinguished international speakers who are expected to participate and provide insights and expert opinion on a wide range of topics in pulmonary and respiratory medicine.I hope that you will enjoy the Congress and that your interaction with your colleagues from different countries will stimulate a creative exchange of ideas and will be personally rewarding. I also trust that you will enjoy your visit to the beautiful and exciting city of Shanghai, in November 2011.

Prof. Zhong Nanshan
Honorary Congress President, APSR 2011
Welcome message from the Congress PresidentIt is my great pleasure and honor as Congress President, to welcome you to the 16th Congress of the Asian Pacific Society of Respirology (APSR). The APSR is renowned as a dynamic organization showcasing the breadth and depth of respiratory medicine across the Asia Pacific region. Following the success of the two previous meetings held in China, this year’s congress hosted by Chinese Society of Respiratory Diseases (CSRD) and Shanghai Medical Association, will be held at the Shanghai International Convention Center, in the vibrant and international metropolis of Shanghai. Since its inception and first meeting held in Tokyo in 1988, the congress has gone from strength to strength and we are expecting this year’s meeting to be no exception and continue this momentum to be an outstanding success.Scheduled for the 3 – 6 November 2011, this four-day congress will feature a comprehensive scientific program, including post-graduate courses, lectures and symposia conducted by key note speakers, who are experts in the field of respirology. In addition, oral and poster presentations will provide exposure for researchers, as a platform for academic exchange on exciting new topics currently under investigation. The organizing committee has organized a range of social events and tours to encourage participants to experience the diverse local culture and traditions of the host city.I hope this Congress will be an exciting and productive gathering of respirologists from the Asia Pacific Region and provide an opportunity to share their knowledge, experience and views on current respiratory disease topics, and provide a platform for networking and collaboration between academics and physicians across the region.I would like to thank the APSR 2011 Local Congress Committee for their dedication and support in making this Congress a success and I would also like to thank all participants for their continued interest and involvement in these meetings and look forward to meeting you in November in Shanghai.We invite you to visit the website (www.apsr2011.org) regularly for the latest updates and news about the organization of the Congress.See you in Shanghai in 2011

Prof. Bai Chunxue
Congress President, APSR 2011
-
-
2012.10.15 FDA批准利那洛肽治疗便秘
近日,美国FDA批准了利那洛肽(Linzess,Ironwood制药公司)用于治疗成人慢性特发性便秘和便秘型肠易激综合症(IBS-C)。生产商称:该药(利那洛肽)是鸟苷酸环化酶C(GC-C)激动剂的胶囊制剂,每日口服一次。血浆浓度检测不到的利那洛肽与肠道GC-C结合后,导致细胞内和细胞外
